Bellevue Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-65,900	Closed	-$1.61M	–	221
2021 Q2	$1.61M	Hold	65,900	–	–	0.02%	144
2021 Q1	$1.7M	Buy	65,900 +21,000	+47%	+$924K	0.02%	145
2020 Q4	$2.4M	Hold	44,900	–	–	0.03%	143
2020 Q3	$1.85M	Hold	44,900	–	–	0.03%	145
2020 Q2	$2.18M	Buy	44,900 +2,900	+7%	+$139K	0.03%	133
2020 Q1	$1.77M	Buy	42,000 +2,000	+5%	+$82.4K	0.03%	133
2019 Q4	$1.71M	Sell	40,000 -50,400	-56%	-$2.19M	0.03%	134
2019 Q3	$3.25M	Sell	90,400 -13,400	-13%	-$406K	0.06%	120
2019 Q2	$2.77M	Hold	103,800	–	–	0.05%	121
2019 Q1	$2.79M	Buy	103,800 +8,000	+8%	+$187K	0.15%	96
2018 Q4	$1.55M	Buy	95,800 +38,800	+68%	+$753K	0.11%	101
2018 Q3	$1.18M	Buy	+57,000	New	+$897K	0.08%	122
2018 Q2	–	Sell	-34,550	Closed	-$776K	–	139
2018 Q1	$776K	Sell	34,550 -500	-1%	-$13.8K	0.08%	113
2017 Q4	$1.05M	Sell	35,050 -81,950	-70%	-$2.62M	0.11%	109
2017 Q3	$4.41M	Sell	117,000 -69,000	-37%	-$2.24M	0.46%	57
2017 Q2	$5.85M	Buy	186,000 +141,000	+313%	+$4.2M	0.69%	54
2017 Q1	$1.55M	Hold	45,000	–	–	0.21%	87
2016 Q4	$1.3M	Hold	45,000	–	–	0.27%	79
2016 Q3	$1.43M	Hold	45,000	–	–	0.26%	86
2016 Q2	$1.46M	Hold	45,000	–	–	0.27%	85
2016 Q1	$1.26M	Buy	+45,000	New	+$981K	0.23%	91